Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription 30.07.2018 2 Am J Hematol 3 Ann Hematol 1 Blood 1 BMC Cancer 1 Bone Marrow Transplant 1 Eur J Haematol 2 Hematol Oncol Clin North Am 2 Int J Hematol 1 J Clin Oncol 3 J Pediatr Hematol Oncol 2 J Virol 4 Leukemia 1 Oncogene 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. SARACENI F, Beohou E, Labopin M, Arcese W, et al
   Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.
   Am J Hematol. 2018 Jul 23. doi: 10.1002/ajh.25225.
   PubMed     Text format     Abstract available
   
   
2. OHANIAN M, Garcia-Manero G, Levis M, Jabbour E, et al
   Sorafenib Combined with 5-azacytidine (AZA) in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid Leukemia (AML).
   Am J Hematol. 2018 Jul 20. doi: 10.1002/ajh.25198.
   PubMed     Text format     Abstract available
   
   

   
   Ann Hematol

3. GU B, Zhang X, Chen G, Wu X, et al
   Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia.
   Ann Hematol. 2018 Jul 23. pii: 10.1007/s00277-018-3428.
   PubMed     Text format     Abstract available
   
   
4. PARK E, Jue MS
   Radotinib-induced eruptive melanocytic nevi in patient with chronic myeloid leukemia: a case report and literature review.
   Ann Hematol. 2018 Jul 21. pii: 10.1007/s00277-018-3444.
   PubMed     Text format    
   
   
5. BURNS TF, Loo EY, Bengtson EM, Bao L, et al
   Cytogenetically cryptic insertion of PML segment into RARA on chromosome 17q resulting PML-RARA fusion in acute promyelocytic leukemia.
   Ann Hematol. 2018 Jul 20. pii: 10.1007/s00277-018-3399.
   PubMed     Text format    
   
   

   
   Blood

6. 
   Ambiguous lineage leukemia treatment.
   Blood. 2018;132:343.
   PubMed     Text format    
   
   

   
   BMC Cancer

7. SHEN Z, Gu X, Mao W, Yin L, et al
   Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis.
   BMC Cancer. 2018;18:755.
   PubMed     Text format     Abstract available
   
   

   
   Bone Marrow Transplant

8. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
   Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
   Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
   PubMed     Text format    
   
   

   
   Eur J Haematol

9. MURAI K, Yamaguchi K, Ito S, Miyagishima T, et al
   Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients.
   Eur J Haematol. 2018;100:27-35.
   PubMed     Text format     Abstract available
   
   

   
   Hematol Oncol Clin North Am

10. SAVAGE SA, Walsh MF
    Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
    Hematol Oncol Clin North Am. 2018;32:657-668.
    PubMed     Text format     Abstract available
    
    
11. SCHAEFER EJ, Lindsley RC
    Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
    Hematol Oncol Clin North Am. 2018;32:643-655.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hematol

12. NAKASHIMA J, Imaizumi Y, Taniguchi H, Ando K, et al
    Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.
    Int J Hematol. 2018 Jul 21. pii: 10.1007/s12185-018-2509.
    PubMed     Text format     Abstract available
    
    
13. ITAMURA H, Ide M, Sato A, Sueoka-Aragane N, et al
    Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
    Int J Hematol. 2018 Jul 24. pii: 10.1007/s12185-018-2506.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

14. YEOH AEJ, Lu Y, Chin WHN, Chiew EKH, et al
    Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study.
    J Clin Oncol. 2018 Jul 25:JCO2018783050. doi: 10.1200/JCO.2018.78.3050.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Hematol Oncol

15. POUKKA M, Lund-Aho T, Raittinen P, Nikkila A, et al
    Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment.
    J Pediatr Hematol Oncol. 2018 Jul 24. doi: 10.1097/MPH.0000000000001267.
    PubMed     Text format     Abstract available
    
    
16. YAMADA A, Kinoshita M, Sawa D, Saito Y, et al
    Long-term Remission of Acute Myeloid Leukemia Developed From Systemic Mastocytosis by Conventional Chemotherapy.
    J Pediatr Hematol Oncol. 2018 Jul 23. doi: 10.1097/MPH.0000000000001259.
    PubMed     Text format     Abstract available
    
    
17. MANKUZHY NP, Walling E, Anderson B, Mody R, et al
    Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Jul 19. doi: 10.1097/MPH.0000000000001249.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

18. MARTIN JL, Mendonca L, Marusinec R, Zuczek J, et al
    Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
    J Virol. 2018 Apr 25. pii: JVI.00333-18. doi: 10.1128/JVI.00333.
    PubMed     Text format     Abstract available
    
    
19. RUSHING AW, Hoang K, Polakowski N, Lemasson I, et al
    The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

20. LEEKSMA AC, Taylor J, Wu B, Gardner JR, et al
    Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
    Leukemia. 2018 Jul 23. pii: 10.1038/s41375-018-0215.
    PubMed     Text format     Abstract available
    
    
21. KREITMAN RJ, Dearden C, Zinzani PL, Delgado J, et al
    Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.
    Leukemia. 2018 Jul 20. pii: 10.1038/s41375-018-0210.
    PubMed     Text format     Abstract available
    
    
22. ALDOSS I, Capelletti M, Park J, Pistofidis RS, et al
    Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.
    Leukemia. 2018 Jul 19. pii: 10.1038/s41375-018-0213.
    PubMed     Text format     Abstract available
    
    
23. CICCONI L, Fenaux P, Kantarjian H, Tallman M, et al
    Molecular remission as a therapeutic objective in acute promyelocytic leukemia.
    Leukemia. 2018 Jul 19. pii: 10.1038/s41375-018-0219.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

24. FERRANDINO F, Bernardini G, Tsaouli G, Grazioli P, et al
    Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0401.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. MAHGOUB M, Yasunaga JI, Iwami S, Nakaoka S, et al
    Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.
    Proc Natl Acad Sci U S A. 2018;115:E1269-E1278.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: